NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 50 min ago
Role of Environmental Stress in the Health Inequities of Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-24-024 from the NIH Guide for Grants and Contracts. The goal of this initiative is to increase our knowledge of how environmental stressors such as heat, crowding, air quality, noise, violence, and adverse childhood experiences in lower resourced communities affect Alzheimers Disease Related Dementias (ADRD). These and other noninheritable factors are collectively known as the exposome and includes environmental stress which is a major factor in racial and ethnic health inequities. ADRD is more prevalent and severe in people who live in lower resourced environments, and there is a need to identify the most important risk factors and determine their mechanistic underpinnings.
Categories: Job Watch, Literature Watch
Notice of Change to Application Instructions for RFA-HL-24-012 Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed)
Notice NOT-HL-23-104 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Participation of NIBIB in "RFA-NS-22-025 HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)"
Notice NOT-EB-23-013 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Participation of NIBIB in "RFA-NS-22-022 HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)"
Notice NOT-EB-23-015 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Award Budget in RFA-RM-23-013 "Partnerships with Common Fund Data Ecosystem Resources (U24 Clinical Trial not Allowed)"
Notice NOT-RM-23-022 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Budget Form and Budget Instructions for RFA-RM-23-004 "NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)"
Notice NOT-RM-23-021 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Application Project Period in RFA-MD-23-003, "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)"
Notice NOT-MD-23-012 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NLM Withdrawal of Participation from PAR-21-277 Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)
Notice NOT-LM-23-004 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Lymphatic System in Health and Disease (R01)
Notice NOT-HL-23-099 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Application Instructions for RFA-HL-24-007 Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordinating Center (U24- Clinical Trial Not Allowed)
Notice NOT-HL-23-103 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Understanding Immune Evasion in Tickborne Diseases
Notice NOT-AI-23-053 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Addressing Organizational Factors to Prevent or Mitigate Nurse Burnout
Notice NOT-NR-23-012 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change: Extension of PAR-20-285 "NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)"
Notice NOT-NS-23-094 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Key Dates for PAR-23-029, NCMRR Early Career Research Award (R03 Clinical Trial Optional)
Notice NOT-HD-23-019 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Request for Information (RFI) on Opportunities for Biomarker Research in Amyotrophic Lateral Sclerosis (ALS)
Notice NOT-NS-23-097 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-24-014 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIH Blueprint R25 program is to encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical, behavioral, and clinical research workforce, to pursue further studies or careers in research. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development, Research Experiences, and Mentoring Activities.The fully integrated educational activities should prepare undergraduate students from diverse backgrounds, including those from groups underrepresented in biomedical and behavioral sciences to enter Ph.D. degree programs in the neurosciences. To accomplish this goal, this initiative will provide institutional awards to develop neuroscience research education programs comprised of collaborative partnerships integrated across different educational institution types. Each partnership must include: a) one or more institutions that either: 1) have a historical and current mission to educate students from any of the populations that have been identified as underrepresented in biomedical research as defined by the National Science Foundation NSF, see http://www.nsf.gov/statistics/wmpd/) (i.e., African Americans or Blacks, Hispanic or Latino Americans, American Indians, Alaska Natives, Native Hawaiians, U.S. Pacific Islanders, and persons with disabilities) or 2) have a documented track record of recruiting, training and/or educating, and graduating underrepresented students as defined by NSF (see above), which has resulted in increasing the institution's contribution to the national pool of graduates from underrepresented backgrounds who pursue biomedical research careers; b) a research-intensive institution that has an established neuroscience or neuroscience-related program; c) integrated
Categories: Job Watch, Literature Watch
Notice of Need to Expire and Reissue NOT-AT-21-013 "Notice of Special Interest: National Center for Complementary and Integrative Health (NCCIH) T32 Supplement Program for Pre and Postdoctoral Candidates from Diverse Backgrounds" to Change the Due Dates
Notice NOT-AT-24-011 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Eligibility Criteria for RFA-HL-23-007 Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
Notice NOT-HL-23-100 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-246 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize mechanistic studies toward fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. These studies should be performed in context of research concerning the delivery of nanoparticles and/or nano-devices to desired and intended cancer targets in vivo and/or characterization of detection and diagnostic devices in vitro. IRCN awards are expected to produce fundamental knowledge to aid future and more informed development of nanotechnology-based cancer interventions. The clinical translation of these interventions is outside of the scope of this NOFO.
Categories: Job Watch, Literature Watch
Notice of a Question and Answer "Office Hour" with NIGMS Staff for Bridges to the Baccalaureate and Bridges to the Doctorate Applicants
Notice NOT-GM-23-050 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch